1. Studies on the anticancer and streptolysin-forming abilities of hemolytic streptococci;Okamoto;Jpn. J Microbiol,1967
2. Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferonalfa 2 and OK-432;Nio;Cancer Immunol Immunother,1988
3. The preclinical screening laboratory; evaluation of immunomoderatpry and therapeutical properties of biological response modifiers;Talmadge;Cancer Treat Rep,1986
4. Clinical studies on cell-mediated immunity in patients with malignant disease: I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro;Uchida;Cancer,1980
5. A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: fourth study. Clinical application of OK-432 for control of cancer;Yamamura;Excerpta Med,1986